Results 51 to 60 of about 21,011 (152)

Risk definition and management strategies in retinoblastoma: current perspectives

open access: yesClinical Ophthalmology, 2015
Fariba Ghassemi, Alireza Khodabande Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Tehran Province, Islamic Republic of Iran Abstract: This manuscript focuses on high-risk factors of metastatic disease in ...
Ghassemi F, Khodabande A
doaj  

Cutaneous toxicity following intra-arterial chemotherapy with melphalan for uveal melanoma: A case report

open access: yesCurrent Problems in Cancer: Case Reports
Background: This case report aims to describe an adverse reaction following intra-arterial melphalan chemotherapy in a 48-year-old female patient with choroidal melanoma.
Arthur Sampaio Zupelli   +6 more
doaj   +1 more source

Atypical Event Profiling of Intra-Arterial Chemotherapy. [PDF]

open access: yesJ Vitreoretin Dis, 2022
Bach A, Villegas VM, Gold AS, Murray TG.
europepmc   +1 more source

Incidence and Risk Factors for Neutropenia After Intra-Arterial Chemotherapy for Retinoblastoma.

open access: yesJAMA Ophthalmol, 2023
Lee DH   +4 more
europepmc   +1 more source

Effectiveness of Intra-Arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma: Relevance of a Multidisciplinary Setting. [PDF]

open access: yesClin Ophthalmol, 2023
Castela G   +9 more
europepmc   +1 more source

Ocular survival after intra-arterial chemotherapy for retinoblastoma improves with accrual of experience and programmatic evolution. [PDF]

open access: yesPediatr Blood Cancer, 2023
Marasligiller SA   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy